Your browser doesn't support javascript.
Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22.
Melidou, Angeliki; Ködmön, Csaba; Nahapetyan, Karen; Kraus, Annette; Alm, Erik; Adlhoch, Cornelia; Mooks, Piers; Dave, Nishi; Carvalho, Carlos; Meslé, Margaux Mi; Daniels, Rodney; Pebody, Richard.
  • Melidou A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Ködmön C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Nahapetyan K; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Kraus A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Alm E; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Adlhoch C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Mooks P; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Dave N; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Carvalho C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Meslé MM; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Daniels R; WHO Collaborating Centre, Francis Crick Institute, London, United Kingdom.
  • Pebody R; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Euro Surveill ; 27(15)2022 04.
Artículo en Inglés | MEDLINE | ID: covidwho-1869326
ABSTRACT
In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections were confirmed. Substantial proportions of characterised circulating virus subtypes or lineages differed antigenically from their respective northern hemisphere vaccine components. Appropriate levels of influenza virus characterisations should be maintained until the season end and in future seasons, when surveillance is adapted to integrate SARS-CoV-2.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / COVID-19 Tipo de estudio: Estudio observacional Tópicos: Vacunas Límite: Humanos Idioma: Inglés Asunto de la revista: Enfermedades Transmisibles Año: 2022 Tipo del documento: Artículo País de afiliación: 1560-7917.Es.2022.27.15.2200255

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / COVID-19 Tipo de estudio: Estudio observacional Tópicos: Vacunas Límite: Humanos Idioma: Inglés Asunto de la revista: Enfermedades Transmisibles Año: 2022 Tipo del documento: Artículo País de afiliación: 1560-7917.Es.2022.27.15.2200255